Cargando…
Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms
Neuroendocrine neoplasia (NEN) is an umbrella term that includes a widely heterogeneous disease group including well-differentiated neuroendocrine tumours (NETs), and aggressive neuroendocrine carcinomas (NECs). The site of origin of the NENs is linked to the intrinsic tumour biology and is predicti...
Autores principales: | Iravani, Amir, Parihar, Ashwin Singh, Akhurst, Timothy, Hicks, Rodney J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164531/ https://www.ncbi.nlm.nih.gov/pubmed/35659779 http://dx.doi.org/10.1186/s40644-022-00465-3 |
Ejemplares similares
-
The Effects of Radioligand Therapy on Quality of Life and Sexual Function in Patients with Neuroendocrine Neoplasms
por: Malandrino, Pasqualino, et al.
Publicado: (2022) -
Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms
por: Saracyn, Marek, et al.
Publicado: (2022) -
Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy
por: Halfdanarson, Thorvardur R., et al.
Publicado: (2023) -
Diagnosis in Neuroendocrine Neoplasms: From Molecular Biology to Molecular Imaging
por: Manneh Kopp, Ray, et al.
Publicado: (2022) -
Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN)
por: Kong, Grace, et al.
Publicado: (2023)